Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
FBRX compared with NERV: revenue, margins and what each company keeps, and the suppliers and customers both name
FBRX
Forte Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
NERV
Minerva Neurosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
FBRX
Forte Biosciences, Inc.
vs
NERV
Minerva Neurosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
FBRX
No earnings history for FBRX.
NERV
2 of 4 reports
0 of 2
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
thin chain
±48.8%
▲
+5.22%
×0.11
Q2 FY26
±82.1%
▼
−3.83%
×0.05
= implied
FBRX realized, solid
NERV realized, hatched
One scale, both sides: full bar = 83%
× = |realized| ÷ implied
Source: market data
FBRX
Forte Biosciences, Inc.
Change
76.99
▲
+0.03%
· post 77.01
Mkt cap
$1.6B
NERV
Minerva Neurosciences, Inc.
Change
2.40
▲
+4.42%
· post 2.25
Closed
Nov 6 '26
Mkt cap
$120.6M
vs
Compare
Closed
Nov 6 '26
FBRX
Forte Biosciences, Inc.
vs
NERV
Minerva Neurosciences, Inc.
76.99
▲
+0.03%
post 77.01
Price
2.40
▲
+4.42%
post 2.25
$1.6B
Mkt cap
$120.6M
Change
Change
FBRX
76.99
▲
+0.03%
vs
NERV
2.40
▲
+4.42%
Closed
Nov 6 '26